Page 177 - TD-3-4

Tumor Discovery Sarcomatoid mesothelioma: A case report

obtained permission to reprint any figures or tables that doi: 10.1038/s41598-024-58117-4
were initially printed elsewhere, should they be required. 10. Mann S, Khawar S, Moran C, et al. Revisiting localized
malignant mesothelioma. Ann Diagn Pathol. 2019;39:74-77.
Availability of data
doi: 10.1016/j.anndiagpath.2019.02.014
Data are available from the corresponding author upon
reasonable request. 11. Finn RS, Brims FJH, Gandhi A, et al. Postmortem findings
of malignant pleural mesothelioma: A two-center study of
References 318 patients. Chest. 2012;142(5):1267-1273.
doi: 10.1378/chest.11-3204
1. Alpert N, van Gerwen M, Taioli E. Epidemiology of
mesothelioma in the 21 century in Europe and the United 12. Pezzuto A, Mariotta S, Fioretti F, et al. Metastasis to the colon
st
States, 40 years after restricted/banned asbestos use. Transl from lung cancer presenting with severe hyponatremia and
Lung Cancer Res. 2020;9(Suppl 1):S28-S38. dyspnea in a young male: A case report and review of the
literature. Oncol Lett. 2013;5(5):1477-1480.
doi: 10.21037/tlcr.2019.11.11
doi: 10.3892/ol.2013.1208
2. Billè A, Okiror L, Harling L, et al. Analysis of survival of
patients with metastatic malignant pleural mesothelioma. 13. Agaimy A, Wünsch PH. Epithelioid and sarcomatoid
Tumori. 2021;107(2):110-118. malignant pleural mesothelioma in endoscopic
gastric biopsies: A diagnostic pitfall. Pathol Res Pract.
doi: 10.1177/0300891620926239
2006;202(8):617-622.
3. Mott FE. Mesothelioma: A review. Ochsner J. 2012;12(1):70-79.
doi: 10.1016/j.prp.2006.05.002
4. Klebe S, Brownlee NA, Mahar A, et al. Sarcomatoid
mesothelioma: A clinical-pathologic correlation of 14. Clopton B, Long W, Santos M, Asarian A, Genato R, Xiao P.
326 cases. Modern Pathol. 2010;23(3):470-479. Sarcomatoid mesothelioma: Unusual findings and literature
review. J Surg Case Rep. 2022;2022(11):rjac512.
doi: 10.1038/modpathol.2009.180
doi: 10.1093/jscr/rjac512
5. Leigh J, Rogers AJ, Ferguson DA, et al. Lung asbestos fiber 15. Mehta K, Mehta S, Joshi M, Bharadwaj HR, Ardeshana G,
content and mesothelioma cell type, site, and survival. Tenkorang PO. Challenging diagnosis of sarcomatoid
Cancer. 1991;68(1):135-141.
hepatic mesothelioma: A case report with review of
doi: 10.1002/1097-0142(19910701)68:1<135:AID-CNCR28 literature. Ann Med Surg (Lond). 2023;85(10):5123-5126.
20680125>3.0.CO;2-S
doi: 10.1097/MS9.0000000000001148
6. Huang J, Chan SC, Pang WS, et al. Global incidence, risk 16. Amatya VJ, Kushitani K, Mawas AS, et al. MUC4, a
factors, and temporal trends of mesothelioma: A population- novel immunohistochemical marker identified by gene
based study. J Thorac Oncol. 2023;18(6):792-802.
expression profiling, differentiates pleural sarcomatoid
doi: 10.1016/j.jtho.2023.01.095 mesothelioma from lung sarcomatoid carcinoma. Mod
Pathol. 2017;30(5):672-681.
7. Hernández-Blanquisett A, Álvarez-Londoño A, Martinez-
Avila MC, et al. Asbestos and cancer in Latin America and doi: 10.1038/modpathol.2016.181
the Caribbean: We may have won some battles, but definitely 17. Assié JB, Crépin F, Grolleau E, et al. Immune-checkpoint
not the war. J Public Health Res. 2021;11(2):2549.
inhibitors for malignant pleural mesothelioma: A French,
doi: 10.4081/jphr.2021.2549 multicenter, retrospective real-world study. Cancers (Basel).
2022;14(6):1498.
8. Singh R, Frank AL. Analysis of the Indian Government’s
position on the use of asbestos and its health effects. Public doi: 10.3390/cancers14061498
Health Action. 2023;13(2):50-52.
18. Mansfield AS, Symanowski JT, Peikert T. Systematic
doi: 10.5588/pha.23.0013 review of response rates of sarcomatoid malignant
pleural mesotheliomas in clinical trials. Lung Cancer.
9. Li X, Ding D, Xie W, et al. Risk assessment and source
analysis of heavy metals in soil around an asbestos mine in 2014;86(2):133-136.
an arid plateau region, China. Sci Rep. 2024;14(1):7552. doi: 10.1016/j.lungcan.2014.08.017

Volume 3 Issue 4 (2024) 4 doi: 10.36922/td.4420